NASDAQ:CYCN

Cyclerion TherapeuticsInc. Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$2.85

-0.00010000 (-0.0035%)

At Close: May 17, 2024

Currently predicting for Mon, 20 May 2024

Trading levels for CYCN

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	2.85	.
		R2	2.85	.
		R1	2.85	.
Current price:			2.85
	Support	S1	2.85	.
		S2	2.85	.
		S3	2.85	.

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	3.37	18.25 %
		R2	3.20	12.28 %
		R1	3.01	5.61 %
Current price			2.85
	Support	S1	2.83	-0.702%
		S2	2.82	-1.05%
		S3	2.80	-1.75%

CYCN Predictions History

4 years ago
StockVader predicted that CYCN for 2019-09-17 is going

4 years ago
Rookie predicted that CYCN for 2019-09-17 is going

Rank:

About Cyclerion TherapeuticsInc.

Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, as well as Alzheimer's dis... CYCN Profile

Golden Star

Ticker	Date	Change	Price
LYV	May 15	0.114%	$96.48
RL	May 15	0.539%	$166.98
PAGS	May 15	0.157%	$12.74
EVBG	May 15	0.230%	$34.79
INBX	May 15	0.96%	$34.37
CME	May 14	1.11%	$210.80
VGIT	May 14	0.173%	$57.83
VCLT	May 14	0.726%	$75.73
BNDX	May 14	0.267%	$48.60
FIXD	May 14	0.303%	$42.89

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In